| 1 |
33972250 | Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting. | 2021 Jul 16 |
1 |
| 2 |
32816727 | Emergence of Carbapenem-Resistant Providencia rettgeri and Providencia stuartii Producing IMP-Type Metallo-β-Lactamase in Japan. | 2020 Oct 20 |
2 |
| 3 |
28614759 | Structure-activity relationship study and optimisation of 2-aminopyrrole-1-benzyl-4,5-diphenyl-1H-pyrrole-3-carbonitrile as a broad spectrum metallo-β-lactamase inhibitor. | 2017 Sep 8 |
1 |
| 4 |
27139465 | Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases. | 2016 Jul |
1 |
| 5 |
25918145 | Meropenem and chromacef intermediates observed in IMP-25 metallo-β-lactamase-catalyzed hydrolysis. | 2015 Jul |
1 |
| 6 |
23954421 | An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases. | 2013 Dec |
1 |
| 7 |
23006757 | The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure. | 2012 Dec |
1 |
| 8 |
11302793 | Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. | 2001 May |
1 |